Rxo (RXO) Market Capitalization (2022 - 2026)

Rxo (RXO) has reported Market Capitalization for 5 consecutive years, with $4.6 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 76.53% year-over-year to $4.6 billion; the trailing twelve-month figure through Jun 2026 stood at $4.6 billion (up 76.53% YoY), and the FY2025 full-year result was $2.1 billion, down 34.76% from the prior year.
• Market Capitalization advanced to $4.6 billion in Q2 2026 per RXO's latest filing, from $2.4 billion in the prior quarter.
• Across five years, Market Capitalization topped out at $4.6 billion in Q2 2026 and bottomed at $2.0 billion in Q4 2022.
• Historically, Market Capitalization has averaged $2.8 billion across 5 years, with a median of $2.6 billion in 2025.
• The sharpest annual moves came in 2024 and 2025: Market Capitalization jumped 95.03% in 2024, then tumbled 43.94% in 2025.
• Over 5 years, Market Capitalization stood at $2.0 billion in 2022, then surged by 35.96% to $2.7 billion in 2023, then increased by 16.84% to $3.2 billion in 2024, then slumped by 34.76% to $2.1 billion in 2025, then soared by 119.29% to $4.6 billion in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $4.6 billion, $2.4 billion, and $2.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.